Cargando…

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication

Detalles Bibliográficos
Autores principales: Huo, Yu-Jia, Xu, Peng-Peng, Fu, Di, Yi, Hong-Mei, Huang, Yao-Hui, Wang, Li, Wang, Nan, Ji, Meng-Meng, Liu, Qing-Xiao, Shi, Qing, Wang, Shuo, Cheng, Shu, Feng, Yan, Zhao, Wei-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964673/
https://www.ncbi.nlm.nih.gov/pubmed/35351868
http://dx.doi.org/10.1038/s41408-022-00644-2
_version_ 1784678269403004928
author Huo, Yu-Jia
Xu, Peng-Peng
Fu, Di
Yi, Hong-Mei
Huang, Yao-Hui
Wang, Li
Wang, Nan
Ji, Meng-Meng
Liu, Qing-Xiao
Shi, Qing
Wang, Shuo
Cheng, Shu
Feng, Yan
Zhao, Wei-Li
author_facet Huo, Yu-Jia
Xu, Peng-Peng
Fu, Di
Yi, Hong-Mei
Huang, Yao-Hui
Wang, Li
Wang, Nan
Ji, Meng-Meng
Liu, Qing-Xiao
Shi, Qing
Wang, Shuo
Cheng, Shu
Feng, Yan
Zhao, Wei-Li
author_sort Huo, Yu-Jia
collection PubMed
description
format Online
Article
Text
id pubmed-8964673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89646732022-04-12 Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication Huo, Yu-Jia Xu, Peng-Peng Fu, Di Yi, Hong-Mei Huang, Yao-Hui Wang, Li Wang, Nan Ji, Meng-Meng Liu, Qing-Xiao Shi, Qing Wang, Shuo Cheng, Shu Feng, Yan Zhao, Wei-Li Blood Cancer J Correspondence Nature Publishing Group UK 2022-03-29 /pmc/articles/PMC8964673/ /pubmed/35351868 http://dx.doi.org/10.1038/s41408-022-00644-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Huo, Yu-Jia
Xu, Peng-Peng
Fu, Di
Yi, Hong-Mei
Huang, Yao-Hui
Wang, Li
Wang, Nan
Ji, Meng-Meng
Liu, Qing-Xiao
Shi, Qing
Wang, Shuo
Cheng, Shu
Feng, Yan
Zhao, Wei-Li
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
title Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
title_full Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
title_fullStr Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
title_full_unstemmed Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
title_short Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
title_sort molecular heterogeneity of cd30+ diffuse large b-cell lymphoma with prognostic significance and therapeutic implication
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964673/
https://www.ncbi.nlm.nih.gov/pubmed/35351868
http://dx.doi.org/10.1038/s41408-022-00644-2
work_keys_str_mv AT huoyujia molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT xupengpeng molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT fudi molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT yihongmei molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT huangyaohui molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT wangli molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT wangnan molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT jimengmeng molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT liuqingxiao molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT shiqing molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT wangshuo molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT chengshu molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT fengyan molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication
AT zhaoweili molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication